In combination with the results of the present review it becomes even more apparent that there is a strong need for clarification in terms of the PANSS calculation: Although some authors use ...

It appears shareholders were spooked by the size of the reduction in PANSS – a 7.5 improvement on placebo and an 18.2-point fall from baseline – compared to similarly-acting rival therapies in ...

与安慰剂相比，所有剂量的LB-102可显著改善急性精神分裂症成年患者的精神分裂症阳性和阴性症状量表（PANSS）总分。根据此结果，该公司预计将LB ...

In the 81-patient phase 1b trial, CVL-231 was able to achieve significant reductions in the Positive and Negative Syndrome Scale (PANSS) of schizophrenia symptoms, compared to both placebo and ...

Background: The PANSS (Positive and Negative Syndrome Scale) is one of the most important rating instruments for patients with schizophrenia. Nevertheless, there is a long and ongoing debate in ...